Patents by Inventor Vanessa Bruat

Vanessa Bruat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA
    Publication number: 20100144538
    Abstract: The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to SCHIZOPHRENIA disease and/or their response to a particular drug or drugs.
    Type: Application
    Filed: March 10, 2008
    Publication date: June 10, 2010
    Inventors: Abdelmajid Belouchi, John Verner Raelson, Walter Edward Bradley, Bruno Paquin, Helene Fournier, Pascal Croteau, Nouzha Paquin, Daniel Dubois, Vanessa Bruat, Paul Van Eerdewegh, Jonathan Segal, Randall David Little, Tim Keith
  • GENEMAP OF THE HUMAN GENES ASSOCIATED WITH ADHD
    Publication number: 20100120628
    Abstract: The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to ADHD disease and/or their response to a particular drug or drugs.
    Type: Application
    Filed: February 6, 2008
    Publication date: May 13, 2010
    Applicant: GENIZON BIOSCIENCES INC.
    Inventors: Abdelmajid Belouchi, Vanessa Bruat, Pascal Croteau, Daniel Dubois, Randall David Little, Bruno Paquin, John Verner Raelson, Jonathan Segal, Paul Van Eerdewegh, Sandie Briand, Sem Kebache, Tim Keith
  • CROHN DISEASE SUSCEPTIBILITY GENE
    Publication number: 20100099083
    Abstract: The present invention relates to the ATG16l1 gene and genetic variants associated with Crohn's disease. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to Crohn's disease and/or their response to a particular drug or drugs.
    Type: Application
    Filed: July 26, 2007
    Publication date: April 22, 2010
    Applicant: GENIZON BIOSCIENCES INC
    Inventors: John Verner Raelson, Stefan Schreiber, Randall David Little, Andre Franke, Jochen Hampe, Tim Keith, Vanessa Bruat, Abdelmajid Belouchi